Chemidex Pharma Ltd have taken on responsibility
for Emeside syrup and capsules.
The supply of Emeside syrup will continue
uninterrupted and Chemidex are committed
to replenishing stocks of Emeside capsules
as soon as possible, although there is no
definite availability date at present.
During the period that the capsules remain
unavailable, patients requiring transfer
to the syrup formulation or an alternative
ethosuximide product should be monitored
closely as the different preparations may
cause adverse effects.
| |
 |
|
Epilepsy Research
UK, PO Box 3004, London
W4 4XT
Tel: (+44) (0) 20 8995 4781 • Fax: (+44) (0) 870 838 1069
Registered Charity No. 1100394
|
